AXQ Capital
ELV icon

AXQ Capital’s Elevance Health ELV Stock Holding History

AXQ Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,135
Closed -$1.21M – 1145
2026
Q2 		$1.21M Sell
3,135
-552
-15% -$205K 0.13% 245
2026
Q1 		$1.08M Buy
+3,687
New +$1.21M 0.14% 229
2025
Q4 		– Sell
-1,860
Closed -$601K – 782
2025
Q3 		$601K Buy
+1,860
New +$578K 0.23% 144
2025
Q1 		– Sell
-707
Closed -$261K – 540
2024
Q4 		$261K Sell
707
-470
-40% -$197K 0.12% 286
2024
Q3 		$612K Sell
1,177
-954
-45% -$510K 0.18% 218
2024
Q2 		$1.15M Buy
+2,131
New +$1.13M 0.27% 130
2024
Q1 		– Sell
-1,500
Closed -$707K – 693
2023
Q4 		$707K Sell
1,500
-800
-35% -$370K 0.19% 196
2023
Q3 		$1M Buy
+2,300
New +$1.04M 0.35% 90

Other funds holding ELV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

AXQ Capital's ELV Position: Q3 2026 in Review

AXQ Capital sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 3,135 shares — an estimated $1.21M sold.

AXQ Capital first reported a position in ELV in Q3 2023 and held it in 8 quarters. The position peaked at $1.21M in Q2 2026. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • AXQ Capital reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
  • AXQ Capital sold 3,135 Elevance Health shares in Q3 2026, an estimated $1.21M.
  • AXQ Capital first reported a position in Elevance Health in Q3 2023 and held it in 8 quarters.
  • AXQ Capital's Elevance Health position peaked at $1.21M in Q2 2026.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.